Proto-oncogene transcript levels and acute nonlymphocytic leukemia.
Preisler
H D
HD
Raza
A
A
D000208:Acute Disease; D001752:Blast Crisis; D001853:Bone Marrow / Q000503:physiopathology; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division; D003561:Cytarabine / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D006657:Histones / Q000235:genetics; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000235:genetics*; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D011519:Proto-Oncogenes; D012334:RNA, Neoplasm / Q000235:genetics; D014305:Triose-Phosphate Isomerase / Q000235:genetics
D006657:Histones; C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D012334:RNA, Neoplasm; D003561:Cytarabine; D014305:Triose-Phosphate Isomerase